Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Rising US-Venezuela Tensions, CPC Shutdown Push Oil Prices...

December 4, 2025

Preparations for Maiden Drill Program at Oasis

June 25, 2025

Lode Gold Completes Final Tranche Financing for Total...

August 9, 2025

Angkor’s Energy Subsidiary Completes 2d Seismic Program On...

October 1, 2025

Homerun Resources Inc. Financings Update

October 25, 2025

Crypto Market Update: Sector Rebounds After US$20 Billion...

October 14, 2025

Silver Price Surges Past US$58 to Hit New...

December 2, 2025

Q2 2025 Interim Financial Statements

August 15, 2025

Tech Weekly: Tech Stocks Feel the Heat Amid...

November 8, 2025

Sankamap Metals

December 10, 2025